PHARMOPTIMA Trademark

Trademark Overview

On Monday, November 14, 2016, a trademark application was filed for PHARMOPTIMA with the United States Patent and Trademark Office. The USPTO has given the PHARMOPTIMA trademark a serial number of 87236022. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, July 11, 2023. This trademark is owned by PharmOptima, LLC. The PHARMOPTIMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
pharmoptima

General Information

Serial Number87236022
Word MarkPHARMOPTIMA
Filing DateMonday, November 14, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, July 11, 2023
Registration Number5358005
Registration DateTuesday, December 19, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Pseudo MarkPHARM OPTIMA
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 18, 2016
Primary Code042
First Use Anywhere DateMonday, June 28, 2004
First Use In Commerce DateMonday, June 28, 2004

Trademark Owner History

Party NameGENESIS PHARMOPTIMA, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
Addresshamilton, NJ 08691
Party NameGENESIS PHARMOPTIMA, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHAMILTON, NJ 08690
Party NameGENESIS PHARMOPTIMA, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressHAMILTON, NJ 08690
Party NamePharmOptima, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPortage, MI 49002

Trademark Events

Event DateEvent Description
Friday, September 15, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 11, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, July 11, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 11, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 13, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, December 19, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 19, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Monday, September 18, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 18, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 28, 2017ASSIGNED TO LIE
Wednesday, August 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 22, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 21, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 21, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 21, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, February 21, 2017PRIORITY ACTION E-MAILED
Tuesday, February 21, 2017PRIORITY ACTION WRITTEN
Tuesday, February 21, 2017ASSIGNED TO EXAMINER
Saturday, November 19, 2016NOTICE OF PSEUDO MARK E-MAILED
Friday, November 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 17, 2016NEW APPLICATION ENTERED

Related Keywords

pharmoptima development research pharmaceutical